UPDATE
1-Mayne Pharma nears deal for
Teva assets -source
June 27 (Reuters) - Australia's Mayne
Pharma Group Ltd on Tuesday said it will acquire U.S. generic productsfrom
Teva Pharmaceuticals for $652 million, helping itpropel into the top 2 in the...
